Abstract
Get full access to this article
View all access options for this article.
References
1.
Fox
RJ
Miller
DH
Phillips
JT
. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis . N Engl J Med 2012 ; 367 (12 ): 1087 –97 .
2.
Gold
R
Kappos
L
Arnold
DL
. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis . N Engl J Med 2012 ; 367 (12 ): 1098 –107 .
3.
Delgado-Alvarado
M
Sedano
MJ
González-Quintanilla
V
. Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia . J Neurol Sci 2013 ; 327 (1–2 ): 75 –9 .
4.
Ermis
U
Weis
J
Schulz
JB
. PML in a patient treated with fumaric acid . N Engl J Med 2013 ; 368 (17 ): 1657 –8 .
5.
van Oosten
BW
Killestein
J
Barkhof
F
. PML in a patient treated with dimethyl fumarate from a compounding pharmacy . N Engl J Med 2013 ; 368 (17 ): 1658 –9 .